Effect of conventional and COX-2 selective nonsteroidal antiinflammatory drugs on bone healing;Efeito dos anti-inflamatórios não-esteroidais convencionais e seletivos para COX-2 sobre o reparo ósseo

Acta Ortopedica Brasileira

Volumn 15, Issue 3, 2007, Pages 166-168

  Lamano Carvalho, Teresa Lúcia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone healing; COX 2; Non steroidal anti inflammatory drugs; Prostaglandins

Indexed keywords

EID: 34548759099     PISSN: 14137852     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-78522007000300010     Document Type: Article

References (31)

1. Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on bone, tendon and ligament healing. Inflamma Res 2005; 54:358-366.
2. Carvalho WA, Carvalho RDS, Rios-Santos F. Analgésicos inibidores específicos da ciclooxigenase-2: avanços terapêuticos. Rev Bras Anestesiol 2004; 54:448-464.
3. Gajraj NM. The effect of cyclooxygenase-2 inhibitors on bone healing. Regional Anesthesia and Pain Medicine 2003; 28:456-465.
4. Gerstenfeld LC, Einhorn TA. COX inhibitors and their effects on bone healing. Expert Opin Drug Saf 2004; 3(2):1-6.
5. Melnikova I. Future of COX2 inhibitors. Nature Reviews Drug Discovery 2005; 4:453-454.
6. Raisz LG. Potential impact of selective cycloxygenase-2 inhibitors on bone metabolism in health and disease. Am J med 2001; 110:43S-45S.
7. Kjaersgaard-Andersen P, Nafei A, Teichert G, Kristensen O, Schmidt SA, Keller J, Lucht U. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Acta Orthop Scand 1993; 64(6):639-642.
8. Moore KD, Goss K, Anglen JO. Indomethacin versus radiation therapy for prophylaxix against heterotopic ossification in acetabular fractures: a randomized, prospective study. J Bone Joint Surg Br 1998; 80(2):259-263.
9. Altman RD, Latta LL, Keer R, Renfree K, Hornicek FJ, Banovac K. Effect of nonsteroidal anti-inflammatory drugs on fracture healing: a laboratory study in rats. J Orthop Trauma 1995; 9(5):393-400.
10. Dimar JR 2nd, Ante WA, Zhang YP, Glassman SD. The effect of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine 1996; 21(16):1870-1876.
11. Long J, Lewis S, Kuklo T, Zhu Y, Riew KD. The effect of cyclooxygenase-2 inhibitors on spinal fusion. J Bone Joint Surg Am 2002; 84:1763-1768.
12. Simon AM, Manigrasso MB, O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing. J Bone Mineral Res 2002; 17:963-976.
13. Brown KM, Saunders MM, Kirsch T, Donahue HJ, Reid JS. Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg Am 2004; 86:116-123.
14. Mullis BH, Copland ST, Weinhold PS, Miclau T, Lester GE, Bos GD. Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model. Injury, Int J Care Injured 2006;
15. Ho ML, Chang JK, Wang GJ. Antiinflammatory drug effects on bone repair and remodeling in rabbits. Clin Orthop Relat Res 1995; 313:270-278.
16. Martin GJ, Boden SD, Titus L. Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. Spine 1999; 124(21):2188-2193.
17. Goodman S, Ma T, Trindade M, Ikenoue T, Matsuura I, Wong N, Fox N, Genovese M, Regula D, Smith RL. COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 2002; 20(6):1164-1169.
18. Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn TA. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthopaedic Res 2003; 21:670-675.
19. Pritchett JW. Ketorolac prophylaxix against heterotopic ossification after hip replacement. Clin Orthop Relat Res 1995; 314:162-165.
20. Deguchi M Rapoff AJ, Zdeblick TA. Posterolateral fusion for isthmic spondylolisthesis in adults: analysis of fusion rate and clinical results. J Spinal Disord 1998; 11(6):459-464.
21. Giannoudis PV, MacDonald DA, Matthews SJ, Smith RM, Furlong AJ, De Boer P. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br 2000; 82(5):655-658.
22. Glassman SD, Rose SM, Dimar JR, Puno RM, Campbell MJ, Johnson JR. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 1998; 23(7):834-838.
23. Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg Br 2003; 85(5):700-705.
24. Reuben SS, Ablett D, Kaye R. High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Can Anaesth 2005; 52(5):506-512.
25. Varghese D, Kodakat S, Patel H. Non-steroidal anti-inflammatories should not be used aftr orthopaedic surgery. British Medical Journal 1998; 316(7141):1390.
26. Stone PG, Richards E. NSAIDs need not usually be withheld after orthopaedic surgery. British Medical Journal 1998; 317(7165):1079.
27. Godden D. Effects of NSAIDs on bone healing have been widely reported in maxillofacial journals. British Med J 1999; 318(7191):1141.
28. Goodman S, Ma T, Mitsunaga L, Mivanishi K, Genovese M, Smith RL. Temporal effects of a COX-2 selective NSAID on bone ingrowth. J Biomed Mater Res 2005; 72(3):279-287.
29. Seidenberg AB, An YH. Is there an inhibitory effect of COX-2 inhibitors on bone healing ? Pharmacol Res 2004; 50:151-156.
30. Zhang X, Schwarz EM, Young DA, Puzaz JE, Rosier RN, O'Keef RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109:1405-1415.
31. Reuben SS, Ekman EF. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J Bone Joint Surg Am 2005; 87(3):536-542.